Skip to main content
SpringerLink
Log in

Over-the-Counter Histamine H2-Receptor Antagonists

How will they Affect the Treatment of Acid-Related Diseases?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Andersen M, Schou JS. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status. Pharmacology and Toxicology 69: 253–258, 1991a

    PubMed  CAS  Google Scholar 

  • Andersen M, Schou JS. Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over the counter sale. Ugeskrift for Laeger 20 (153): 1410–1413, 1991b

    Google Scholar 

  • Andersen M, Schou JS. Safety implications of the over-the-counter availability of H2-antagonists. Drug Safety 8: 179–185, 1993

    Article  PubMed  CAS  Google Scholar 

  • Belloc J, Malats N, Porta M, Gallen M. From first symptom to treatment onset: factors influencing patients health seeking behaviour and health care system delay in digestive tract cancer. Proceedings of II United European Gastroenterology Week, Barcelona, July 19–24, p. A132, 1993

  • Blum AL, Chalmers TC, Deutsch F. The Lugano statements on controlled clinical trials. Journal of International Medical Research 15: 2–22, 1987

    PubMed  CAS  Google Scholar 

  • Blum AL, Duroux P, Bauerfeind P. Clinical evaluation of antisecretory agents. In Garner & Whittle (Eds) Advances in drug therapy of gastrointestinal ulceration, pp. 75–87, John Wiley & Sons, New York, 1989

    Google Scholar 

  • Brown D, Vasudeva R, Colliver J, Holt S. Relationship between symptoms and erosive esophagitis, before and after healing?. American Journal of Gastroenterology 84 (9): 1141, 1989

    Google Scholar 

  • Colin-Jones DG, Bloom B, Bodemar G. Management of dyspepsia: report of a working group. Lancet 1: 576–9, 1988

    Google Scholar 

  • Drea EJ. Transition of products from prescription to over the counter: the H2 antagonists. Journal of Pharmacy Practice 5 (1): 22–30, 1992

    Article  Google Scholar 

  • Freston JW. On-demand treatment for duodenal ulcers: has its time come?. American Journal of Gastroenterology 85 (3): 241–242, 1990

    PubMed  CAS  Google Scholar 

  • Gear MW, Barnes RJ. Endoscopic studies of dyspepsia in general practice. British Medical Journal 280: 1136–1137, 1980

    Article  PubMed  CAS  Google Scholar 

  • Heading RC. Chairman’s summary: a round table on dyspepsia. Scandinavian Journal of Gastroenterology 28 (Suppl. 195): 65–66, 1993

    Article  Google Scholar 

  • Heatley RV, Rathbone BJ. Dyspepsia: a dilemma for doctors. Lancet 2: 779–782, 1987

    Article  PubMed  CAS  Google Scholar 

  • Holt S. Alcohol and H2-receptor antagonists: over the counter, under the table?. American Journal of Gastroenterology 85: 516–517, 1990a

    PubMed  CAS  Google Scholar 

  • Holt S. Observations on the relationship between nonulcer dyspepsia and gastric motor function. Gastroenterology Journal Club 2 (3): 9–12, 1990b

    Google Scholar 

  • Holt S. Proton-pump inhibition for acid-related disease. Southern Medical Journal 84: 1078–1087, 1991

    Article  PubMed  CAS  Google Scholar 

  • Holt S, Howden CW. Omeprazole: overview and opinion. Digestive Diseases and Sciences 36 (4): 385–393, 1990

    Article  Google Scholar 

  • Holt S, Saleeby G. Gastric mucosal injury induced by anti-inflammatory drugs (NSAIDs). Southern Medical Journal 84 (3): 355–360, 1990

    Article  Google Scholar 

  • Holt S, Smith M, Guram M, Skinner HA. Computer assessment of lifestyle in a gastroenterology clinic. Digestive Diseases and Sciences 37 (7): 993–996, 1992

    Article  PubMed  CAS  Google Scholar 

  • Holtmann G, Talley NJ. Functional dyspepsia: current treatment recommendations. Drugs 45: 918–930, 1993

    Article  PubMed  CAS  Google Scholar 

  • Howden CW, Holt S. Acid suppression as treatment for NSAlD-related peptic ulcers. American Journal of Gastroenterology 86: 1720–1722, 1991

    PubMed  CAS  Google Scholar 

  • Inoue M, Sekiguchi T, Harasawa S, Miwa T, Miyoshi A. Dyspepsia and dyspepsia subgroups in Japan: symptom profiles and experience with cisapride. Scandinavian Journal of Gastroenterology 28 (Suppl. 195): 36–39, 1993

    Article  Google Scholar 

  • Holt S, Irshad M, Howden CW, Maincro M. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal bleeding. Digestive Diseases and Sciences 38: 1619–1623, 1993

    Article  PubMed  CAS  Google Scholar 

  • Kristensen K. Denmark: H2 antagonists over the counter. Lancet 1: 418, 1992

    Article  Google Scholar 

  • Langman MJS. Antisecretory treatment and predisposition to cancer. In Garner & Whittle (Eds) Advances in drug therapy of gastrointestinal ulceration, pp. 67–73, John Wiley & Sons, New York, 1989

    Google Scholar 

  • Malfertheiner P, Megraud F, Pajares J. European Helicobacter pylori study group: the why, when and how to treat Helicobacter pylori in gastroduodenal disease. Proceedings of II United European Gastroenterology Week, July 19–24, Barcelona, p. 66, 1993

  • Oster G, Huse DM, Delea TE, Colditz GA, Richter JM. The risks and benefits of an Rx-to-OTC switch: the case of over-the-counter H2-blockers. Medical Care 28 (9): 834–852, 1990

    Article  PubMed  CAS  Google Scholar 

  • Petersen H. Over the counter sales of histamine-2 receptor antagonists. Scandinavian Journal of Gastroenterology 155 (Suppl.): 20–22, 1988

    Article  CAS  Google Scholar 

  • Rios-Castellanos E, Sitas F, Shepherd NA, Jewell DP. Changing pattern of gastric cancer in Oxfordshire. Gut 33: 1312–1317, 1992

    Article  PubMed  CAS  Google Scholar 

  • Saleeby G, Howden CW, Holt S. Over the counter (OTC) non-steroidal anti-inflammatory drug (NSAID) use may be an important determinant of complicated peptic ulcer disease (CPUD). American Journal of Gastroenterology 86: 1375, 1991

    Google Scholar 

  • Schiller LR, Fordtran JS. Ulcer complications during short-term therapy of duodenal ulcer with active agents and placebo. Gastroenterology 90: 478–481, 1986

    PubMed  CAS  Google Scholar 

  • Sue-Ling HM, Martin I, Griffith J, Ward DC, Quirke P, et al. Early gastric cancer: 46 cases treated in one surgical department. Gut 33: 1318–1322, 1992

    Article  PubMed  CAS  Google Scholar 

  • Talley NJ. Drug treatment of functional dyspepsia. Scandinavian Journal of Gastroenterology 26 (Suppl. 182): 47–60, 1991

    Article  Google Scholar 

  • Thorat VK, Misra SP, Anand BS. Conventional versus on-demand therapy for duodenal ulcer: results of a controlled therapeutic trial. American Journal of Gastroenterology 85 (3): 243–248, 1990

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Seton Hall University, New Jersey, USA

    Stephen Holt (Chief of Gastroenterology)

  2. Department of Bioengineering, New Jersey Institute of Technology, Roseland, New Jersey, USA

    Stephen Holt (Chief of Gastroenterology)

  3. Long Island College Hospital, Henry Street, Brooklyn, New York, NY 11201, USA

    Stephen Holt (Chief of Gastroenterology)

Authors
  1. Stephen Holt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holt, S. Over-the-Counter Histamine H2-Receptor Antagonists. Drugs 47, 1–11 (1994). https://doi.org/10.2165/00003495-199447010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199447010-00001

Search

Navigation